BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26287396)

  • 1. Modeling Graves' Orbitopathy in Experimental Graves' Disease.
    Banga JP; Moshkelgosha S; Berchner-Pfannschmidt U; Eckstein A
    Horm Metab Res; 2015 Sep; 47(10):797-803. PubMed ID: 26287396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
    Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
    Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.
    Philipp S; Horstmann M; Hose M; Daser A; Görtz GE; Jesenek C; Flögel U; Hansen W; Bechrakis N; Banga JPS; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2022 Mar; 32(3):283-293. PubMed ID: 34779257
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen.
    Berchner-Pfannschmidt U; Moshkelgosha S; Diaz-Cano S; Edelmann B; Görtz GE; Horstmann M; Noble A; Hansen W; Eckstein A; Banga JP
    Endocrinology; 2016 Apr; 157(4):1673-82. PubMed ID: 26872090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical models of Graves' disease and associated secondary complications.
    Moshkelgosha S; So PW; Diaz-Cano S; Banga JP
    Curr Pharm Des; 2015; 21(18):2414-21. PubMed ID: 25777757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
    Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
    Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.
    Görtz GE; Moshkelgosha S; Jesenek C; Edelmann B; Horstmann M; Banga JP; Eckstein A; Berchner-Pfannschmidt U
    Endocrinology; 2016 Oct; 157(10):3771-3778. PubMed ID: 27552248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
    Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
    Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
    [No Abstract]   [Full Text] [Related]  

  • 11. Current insights into the pathogenesis of Graves' orbitopathy.
    Eckstein AK; Johnson KT; Thanos M; Esser J; Ludgate M
    Horm Metab Res; 2009 Jun; 41(6):456-64. PubMed ID: 19530272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA.
    Zhao SX; Tsui S; Cheung A; Douglas RS; Smith TJ; Banga JP
    J Endocrinol; 2011 Sep; 210(3):369-77. PubMed ID: 21715431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
    Park M; Banga JP; Kim GJ; Kim M; Lew H
    Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress and Upregulation of Antioxidant Proteins, Including Adiponectin, in Extraocular Muscular Cells, Orbital Adipocytes, and Thyrocytes in Graves' Disease Associated with Orbitopathy.
    Marique L; Senou M; Craps J; Delaigle A; Van Regemorter E; Wérion A; Van Regemorter V; Mourad M; Nyssen-Behets C; Lengelé B; Baldeschi L; Boschi A; Brichard S; Daumerie C; Many MC
    Thyroid; 2015 Sep; 25(9):1033-42. PubMed ID: 26176182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
    Morshed SA; Ma R; Latif R; Davies TF
    Thyroid; 2022 Apr; 32(4):429-439. PubMed ID: 34927457
    [No Abstract]   [Full Text] [Related]  

  • 17. Animal models of Graves' disease and Graves' orbitopathy.
    Nagayama Y; Nakahara M; Abiru N
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):381-6. PubMed ID: 26181432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Insights into the Pathogenesis of Graves' Ophthalmopathy.
    Bahn RS
    Horm Metab Res; 2015 Sep; 47(10):773-8. PubMed ID: 26361262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
    Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
    Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.